Powers Principal Bill von Oehsen will present to the Kansas State 2021 Special Committee on the Federal 340B Drug Program next week.
The presentation will provide general 340B background information and explain federal program requirements, 340B anti-discrimination laws, pertinent historical, legislative and/or judicial events, and other 340B-related issues of interest to attendees. Bill will also discuss how 340B requirements apply to Kansas 340B covered entities and the need for state legislation to protect the 340B Program.
Bill will provide his testimony to the committee on Wednesday, October 20th.
Bill has extensive experience in general health law, legislation and policy, especially in the areas of pharmaceutical pricing, food and drug law, materials management, managed care and third party reimbursement. He has more than 27 years of experience on pharmaceutical pricing and reimbursement matters, including the 340B drug discount program, the Medicaid drug rebate program, Medicare Part D, Robinson-Patman, and state Medicaid and pharmacy laws. In addition to representing safety-net providers participating in the 340B program, Bill provides guidance to pharmacies, pharmacy-related vendors and consultants, states, local governments, and other healthcare entities in their efforts to improve access to pharmaceutical care and to ensure compliance with drug pricing laws.